Standout Papers

Lipoprotein(a) Reduction in Persons with Cardiovascular Disease 2019 2026 2021 2023 586
  1. Lipoprotein(a) Reduction in Persons with Cardiovascular Disease (2020)
    Sotirios Tsimikas, Ewa Karwatowska‐Prokopczuk et al. New England Journal of Medicine
  2. Volanesorsen and Triglyceride Levels in Familial Chylomicronemia Syndrome (2019)
    Joseph L. Witztum, Daniel Gaudet et al. New England Journal of Medicine
  3. Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk (2021)
    Jean‐Claude Tardif, Ewa Karwatowska‐Prokopczuk et al. European Heart Journal

Immediate Impact

2 by Nobel laureates 9 from Science/Nature 57 standout
Sub-graph 1 of 22

Citing Papers

Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
2025 Standout
Diagnosis and Management of Acute Pancreatitis
2024 Standout

Works of Louis O’Dea being referenced

Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
2020 Standout
Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study
2018

Author Peers

Author Last Decade Papers Cites
Louis O’Dea 1133 693 765 1048 917 48 2.9k
Aldo Galluzzo 1518 284 721 619 576 66 3.6k
Jack Youngren 695 340 1354 437 291 70 3.5k
Sharon J. Elliot 814 176 1228 403 252 86 3.8k
Christine Maric 1563 166 1036 395 1590 56 3.9k
Marija Pfeifer 1362 985 372 293 338 59 2.6k
Michael Bryer‐Ash 947 134 928 543 439 59 2.9k
Deborah Applebaum‐Bowden 1171 130 298 607 373 36 1.9k
Keith Friend 1263 180 798 307 520 52 2.8k
A C Moses 1379 217 1353 423 173 47 3.1k
Timo Koivula 591 173 652 464 344 87 3.4k

All Works

Loading papers...

Rankless by CCL
2026